Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Eleven Biotherapeutics patents new anti-PCSK9 MAbs

Aug. 1, 2014

Regeneron and Sanofi report topline data from nine phase III trials of alirocumab

July 31, 2014

Development of novel potent oxytocin receptor agonists to correct aberrant preterm lactation

July 31, 2014

FDA approves IND for ProHema in children with inherited metabolic disorders

July 30, 2014

Novartis patent describes salts of DGAT1 inhibitor

July 30, 2014

Novo Nordisk receives positive CHMP opinion on Xultophy

July 29, 2014

Essentialis secures grant to advance DCCR in Prader-Willi syndrome

July 28, 2014

CTD Holdings closes private placement to advance Trappsol Cyclo

July 25, 2014

EMA accepts MAA for asfotase alfa as a treatment for hypophosphatasia

July 25, 2014

Wanbang completes first preclinical studies of SBM-TFC-039

July 25, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...